Keytruda Indication for Advanced Gastric Cancer Withdrawn
In September 2017, the FDA granted accelerated approval to Keytruda for recurrent locally advanced or metastatic gastric or GEJ adenocarcinoma.
Gastrointestinal Cancer
The Past, Present, and Future of GRASP: Connecting Cancer Researchers, Clinicians, and Patient Advocates
GRASP co-founder Julia Maués explains how the initiative came about and reveals plans for the future.
Underdosing in Patients With Cancer and Obesity: A Thing of the Past?
New guidelines recommend using the full approved doses of immunotherapy and targeted therapies for patients with cancer and obesity.
Nongenetic Risk Factors for Colorectal Cancer May Differ by Disease Onset, Subsite
Some nongenetic risk factors for late-onset colorectal cancer may not be relevant for early-onset disease.
History of Polyps Raises Colorectal Cancer Risk
Having a first-degree relative with colorectal polyps may increase a person’s risk of developing colorectal cancer, indicating that earlier screening is warranted.
High Body Mass Index Is a Risk Factor for Gallbladder and Biliary Tract Cancer Mortality
A decrease in obesity rates may reduce the burden of gallbladder and biliary tract cancer worldwide, according to the results of a study.
Review of Barriers to Colorectal Cancer Screening in Hard-to-Reach Populations
The COVID-19 pandemic sheds new light on existing access challenges in preventive health care.
- Loading...
Loading...
Next post in Medicine
Loading... 
Loading...